UROX®

UROX is a triple-standardized natural therapy designed to manage kidney stones with near-zero gastrointestinal toxicity. It actively blocks stone formation, breaks down the sticky matrix holding stones together, and gently flushes fragments out through targeted diuresis.

Active Clinical Composition: Dolichos Biflorus
(2 customer reviews)

₨ 795

UROX is a precision-targeted, triple-standardized phytopharmaceutical utilizing DB-Triplex™ Dolichos biflorus (360 mg) to address the metabolic, structural, and hydrodynamic phases of urolithiasis. It operates through a highly engineered Tri-Action Protocol:

  • Phase 1: Block the Enzyme (Anti-Nucleation): HPLC-verified flavonoids (Quercetin) actively downregulate hepatic GAO and renal LDH pathways. This intervention starves the urinary pool of endogenous oxalate, making crystal nucleation biochemically impossible.

  • Phase 2: Break the Matrix (Anti-Aggregation): 98 kDa proteolytic fractions initiate the enzymatic cleavage of mucin and glycoprotein bonds. This directly dissolves the sticky matrix binding the calculus together, shattering aggregations into safely expellable micro-gravel.

  • Phase 3: Flush the Gravel (Hydrodynamic Expulsion): A high concentration of 40-50% total saponins delivers biological surfactant action combined with targeted diuresis. This rapidly drops ureteral surface tension to eliminate friction, providing the high-pressure fluid mechanics required for immediate washout.

  • UROX is indicated for active Medical Expulsive Therapy (MET) and comprehensive recurrence management:

    • Active Expulsion (The MET Adjunct): Optimized for medical expulsive therapy in uncomplicated calculi measuring <9.3mm. It delivers targeted surfactant action and volume expansion to physically drive fragment washout.

    • Post-Surgical Washout (ESWL/PCNL): Enzymatically degrades and flushes Clinically Insignificant Residual Fragments (CIRF) post-surgery before they can act as a nidus for new stone growth.

    • Recurrence Prophylaxis: Delivers equivalent recurrence prevention to standard Potassium Citrate, but operates with zero gastric erosion or dyspepsia, securing absolute long-term patient compliance.

Active SubstanceStrength per Unit
Dolichos Biflorus360mg

* Excipients and coating agents not listed. Refer to full SMPC for complete profile.

  • Mandatory Hydration Requirement: UROX must be administered alongside a strict 2.5 to 3.0L/day fluid intake to facilitate necessary surfactant diuresis.

  • Active Expulsion Protocol: 1 capsule twice daily (BID) for 21 to 45 days.

  • Post-Surgical Washout Protocol: 1 capsule twice daily (BID) for 14 to 21 days immediately following surgical discharge.

  • Recurrence Prophylaxis Protocol: 1 capsule once daily (OD) for continuous metabolic management.

  • Contraindications: UROX is strictly contraindicated in patients suffering from complete ureteral obstruction presenting with severe hydronephrosis, as this condition requires surgical intervention prior to the initiation of any diuretic therapy. It is also contraindicated in patients with End-Stage Renal Disease presenting with anuria.

  • Safety Profile: The DB-Triplex™ formulation presents with near-zero GI toxicity. It is gravimetrically assayed to guarantee a consistent biological yield and is certified free of heavy metals and pesticides.

Scientific Literature & Global Guidelines
  1. Journal of Ethnopharmacology (Elsevier). Diuretic, surfactant, and anti-urolithiatic activity: Implications for Medical Expulsive Therapy.
  2. 3 Biotech (Springer). Assessment of calcium oxalate crystal inhibition potential and mucin-degrading amino acid profiling.
  3. Pharmaceutical Biology (Taylor & Francis). Antinephrolithiatic efficacy of Dolichos biflorus in lithiasic models via GAO/LDH suppression.
  4. Current Traditional Medicine (Bentham Science). Clinical and biochemical modulation of hepatic glycolate oxidase and oxalate supersaturation.
  5. Biointerface Research in Applied Chemistry. Effect of Dolichos biflorus on calcium oxalate crystallization in human urine.
  6. Journal of Pharmacognosy & Phytochemistry. Anti-urolithiatic surfactant and diuretic activity via active saponin isolation.

2 reviews for UROX®

  1. Avatar Of Maria Yaseen

    Maria Yaseen –

    I love Urox specifically for its safe use in kidney stones

  2. Avatar Of Muhammad Abbas

    Muhammad Abbas –

    I have been experiencing kidney stones issues since 2010 and have undergone surgery 3 times. However,the stones continued to form every year usually ranging from 7 mm to 12 mm.A month ago, my cousin recommended Urox tablets, assuring me that they would be beneficial. I used only 10 tablets and Alhumdullillah, the stones were expelled through ureter.
    Based on my personal experience I found this medication effective in reliving my condition.

    • Avatar Of Habib

      Habib –

      Thank you for sharing your experience with Urox Tablets. We truly appreciate you taking the time to provide such detailed feedback.

      We are pleased to know that you found Urox supportive during your condition. Individual results may vary depending on medical history, lifestyle, and adherence, and we always recommend consulting a qualified healthcare professional for proper diagnosis and guidance.

      Your feedback is valuable to us and helps others make informed decisions. We wish you continued health and well-being.

      Warm regards,
      Team Hunoir Pharmaceuticals

Add a review

Your email address will not be published. Required fields are marked *